发明名称 Piperazinderivater
摘要 The present invention is directed to 1,2,3,4,10,10a-hexahydropyrazino [1,2-a]indole derivatives of formula (I): as well as pharmaceutically acceptable salts, hydrates and esters thereof, wherein the substituents have the meanings provided in the specification. Compounds of the present invention may be used in the treatment or prevention of obesity or Type II diabetes.
申请公布号 DK1325008(T3) 申请公布日期 2006.02.13
申请号 DK20010962869T 申请日期 2001.07.24
申请人 F. HOFFMANN-LA ROCHE AG;VERNALIS RESEARCH LIMITED 发明人 HEBEISEN, PAUL;MULLER, MARC;RICHTER, HANS;ROEVER, STEPHAN;MATTEI, PATRIZIO;TAYLOR, SVEN;BENTLEY, JONATHAN, MARK
分类号 C07D487/04;A61K31/337;A61K31/4985;A61K45/00;A61P1/00;A61P3/04;A61P3/10;A61P7/02;A61P9/00;A61P11/00;A61P13/00;A61P15/00;A61P25/00;A61P25/06;A61P25/08;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32 主分类号 C07D487/04
代理机构 代理人
主权项
地址